Phibro Animal Health Sales Gain, but Costs and Currency Pose Risks
Animal Health growth and higher vaccine sales supported Phibro in fiscal 2026, while foreign-exchange losses and input costs weighed on results.
Makkler Newsroom · Oct 8, 08:35 PM · 1 min read
